RCSV research shows efficacy of RLRL therapy in controlling myopia

Research conducted by Prof. HE Mingguang, Director of the Research Centre for SHARP Vision (RCSV) and Chair Professor of Experimental Ophthalmology, has proved that repeated low-level red-light (RLRL) therapy can significantly slow the progression of myopia in children, and can even reverse short-sightedness.

Myopia was considered an irreversible process of axial growth. However, Prof. He found that the axial elongation of children receiving RLRL therapy was 70% less than that of children wearing normal spectacles. Furthermore, multiple clinical studies have demonstrated axial length shortening in up to 40% of RLRL-treated children one month after the therapy.